| mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
-0.014 |
0.9 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |